Dudediligence.

Bausch Health Companies Inc

BHCNYSE · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$2.51BSep ’24$2.56BDec ’24$2.26BMar ’25$2.53BJun ’25$2.68BSep ’25$2.80BDec ’25$2.52BMar ’26$2.85BJun ’26
Net income, by quarter
−$85.0MSep ’24$93.0MDec ’24−$58.0MMar ’25$148.0MJun ’25$179.0MSep ’25−$112.0MDec ’25−$1.42BMar ’26$258.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$8.43B$8.12B$8.76B$9.63B$10.27B
Operating income$450.0M$454.0M$963.0M$1.55B$1.81B
Net income−$948.0M−$225.0M−$592.0M−$46.0M$157.0M
Operating cash flow$1.43B−$728.0M$1.03B$1.60B$1.40B
Free cash flow$1.16B−$946.0M$817.0M$1.26B$1.00B
Cash$582.0M$564.0M$947.0M$1.18B$1.31B
Debt$22.65B$20.77B$22.39B$21.62B$20.82B
Shares outstanding359.4M361.9M365.2M367.8M370.5M